Ads
related to: AGIO
Search results
Agios' (AGIO) Sickle Cell Disease Study Meets Primary Endpoint
Zacks via Yahoo Finance· 10 months agoAgios' (AGIO) mid-stage, label expansion study of mitapivat meets its primary endpoint. The data...
Agios (AGIO) Q2 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 2 years agoAgios Pharmaceuticals' (AGIO) posts encouraging results for the second quarter. The company is...
Agios Pharmaceuticals Inc (AGIO) Reports Q3 2023 Earnings, Reveals 10% Increase in U.S. Net Revenue
GuruFocus.com via Yahoo Finance· 6 months agoAgios Pharmaceuticals Inc (NASDAQ:AGIO) reported U.S. PYRUKYND (mitapivat) net revenue of $7.4...
Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates
Zacks via Yahoo Finance· 3 months agoAgios Pharmaceuticals, Inc. AGIO reported a loss of $1.72 per share in fourth-quarter 2023, wider...
Agios (AGIO) Q4 Earnings Beat Estimates, Revenues Miss
Zacks via Yahoo Finance· 1 year agoAgios Pharmaceuticals, Inc. AGIO announced fourth-quarter 2022 earnings per share of 67 cents,...
Should You Buy Agios Pharmaceuticals (AGIO) After Golden Cross?
Zacks via Yahoo Finance· 10 months agoFrom a technical perspective, Agios Pharmaceuticals, Inc. (AGIO) is looking like an interesting...
An Intrinsic Calculation For Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Suggests It's 48% Undervalued
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Agios Pharmaceuticals fair value estimate...
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks via Yahoo Finance· 1 week agoAgios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark,...
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts...
Simply Wall St. via Yahoo Finance· 6 days agoInvestors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 9.7% to...
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAgios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 14.86% and 29.93%,...
